Lee LH, Hwang JI, Lee TY. Comparable Outcomes of Ultrasound versus Computed Tomography in the Guidance of Radiofrequency Ablation for Hepatocellular Carcinoma PLoS ONE 2017; 12(1): e0169655. DOI: 10.1371/journal.pone.0169655.
Lu SN, Chen CH, Wang JH, Wu CC, Lin SM, Hwang JI, et al. Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan. J Formos Med Assoc 2017; 117:1-23. DOI:10.1016/j.jfma.2017.09.007.
Abi-Jaoudeh N, Fernando D, Nelson K, …Hwang JI, et al. Phase I dose escalating study of hypoxia-activating agent tirapazamine in combination with trans-arterial embolization in patients with intermediate stage hepatocellular carcinoma. J Hepatology 2017; 66:S456 DOI:10.1016/S0168-8278(17)31292-8.
